Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141939 |
| CAS No | NA |
| Mol.F. | C19H20N6O3 |
| Mol.Wt. | 380.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141940 |
| CAS No | NA |
| Mol.F. | C26H32N6O5 |
| Mol.Wt. | 508.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141941 |
| CAS No | NA |
| Mol.F. | C29H30N8O6 |
| Mol.Wt. | 586.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141942 |
| CAS No | NA |
| Mol.F. | C30H32N8O6 |
| Mol.Wt. | 600.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141943 |
| CAS No | NA |
| Mol.F. | C17H19N5O4 |
| Mol.Wt. | 357.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141944 |
| CAS No | NA |
| Mol.F. | C8H9N3O3 |
| Mol.Wt. | 195.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141945 |
| CAS No | NA |
| Mol.F. | C8H7N3O5 |
| Mol.Wt. | 225.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141946 |
| CAS No | NA |
| Mol.F. | C27H26N8O6 |
| Mol.Wt. | 558.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141947 |
| CAS No | NA |
| Mol.F. | C29H31N7O5 |
| Mol.Wt. | 557.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141948 |
| CAS No | NA |
| Mol.F. | C27H27N7O5 |
| Mol.Wt. | 529.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141949 |
| CAS No | NA |
| Mol.F. | C27H27N7O5 |
| Mol.Wt. | 529.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141950 |
| CAS No | NA |
| Mol.F. | C27H28N8O4 |
| Mol.Wt. | 528.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141951 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O7 |
| Mol.Wt. | 466.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141952 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O7 |
| Mol.Wt. | 466.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141953 |
| CAS No | NA |
| Mol.F. | C24H30N2O4 |
| Mol.Wt. | 410.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141954 |
| CAS No | NA |
| Mol.F. | C13H18N6O2 |
| Mol.Wt. | 290.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |